Cross, Matthew
Dearden, Claire
Article History
First Online: 16 April 2020
Compliance with Ethical Standards
:
: Matthew Cross declares that he has no conflict of interest.Claire Dearden has received compensation for participation on advisory boards from Innate Pharma, Roche, Janssen and AbbVie.
: This article does not contain any studies with human or animal subjects performed by any of the authors.